JEFFREY FRIEDLAND

 

Jeffrey Friedland is CEO of US-based FC Global Strategies LLC., which provides strategic advisery services to growing companies globaly and which develops and implements marketing outreach programs using the impact of a video interview coupled with proprietary email and online distribution.

 

Three of these marketing outreach programs are:​

• Medical and Pharma Insider

• Emerging Technology Insider

• Business Connect insider

• Cannabis and Hemp insider

​

Jeffrey Friedland was the chief executive officer and a director of a NASDAQ listed financial services company, a director of a New York Stock Exchange-listed company, and the chairman of a Hong Kong-based company with a stock market listing on the Frankfurt Stock Exchange. 

 

Mr. Friedland has also been the founder, investor, owner, director or member of the executive management of companies in the global cannabis industry, in the United States, Canada, and Israel. 

 

Jeffrey Friedland first traveled to China in 1988, opened an office for Friedland Capital in China in 2003, which was closed due to the financial crisis of 2008.

 

He is an author, speaker and thought leader on emerging and frontier markets, the global economy, renewable energy, and the global cannabis industry.  His books, "All Roads Lead to China - An Investor Road Map to the World's Fastest Growing Economy" and "Marijuana: The World's Most Misunderstood Plant," are available in print and Kindle editions at Amazon. ​

Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, Breitbart, NBC.com and Forbes.

Mr. Friedland is a speaker at conferences and events throughout North America, Europe and Asia, focusing primarily on entrepreneurship, corporate strategies, the global economy, and the medical, pharma, healthcare, technology, telecom, and cannabis industries.  

​